Isracann Biosciences Receives Land Use & Facility Approvals from Israeli Land Authority and Amends Warrants
Approvals pave way for construction as scheduled VANCOUVER, BC, — (November 28, 2019) – Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has received the...